349 related articles for article (PubMed ID: 24823399)
1. Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.
Sasidharanpillai S; Riyaz N; Rajan U; Binitha MP; Khader A; Mariyath OK; John R; Puravoor J
Indian J Dermatol Venereol Leprol; 2014; 80(3):221-8. PubMed ID: 24823399
[TBL] [Abstract][Full Text] [Related]
2. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
5. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
[TBL] [Abstract][Full Text] [Related]
6. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.
Chen YC; Chiu HC; Chu CY
Arch Dermatol; 2010 Dec; 146(12):1373-9. PubMed ID: 20713773
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
Oelze LL; Pillow MT
J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
[TBL] [Abstract][Full Text] [Related]
8. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic management of DRESS: a retrospective study of 38 cases.
Funck-Brentano E; Duong TA; Bouvresse S; Bagot M; Wolkenstein P; Roujeau JC; Chosidow O; Valeyrie-Allanore L
J Am Acad Dermatol; 2015 Feb; 72(2):246-52. PubMed ID: 25592341
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
[TBL] [Abstract][Full Text] [Related]
11. Drug Reaction with Eosinophilia and Systemic Symptoms in Children: A Prospective Study.
Sasidharanpillai S; Sabitha S; Riyaz N; Binitha MP; Muhammed K; Riyaz A; Jayakrishnan MP; Reyila VP
Pediatr Dermatol; 2016; 33(2):e162-5. PubMed ID: 27001334
[TBL] [Abstract][Full Text] [Related]
12. The DRESS syndrome: the great clinical mimicker.
Fleming P; Marik PE
Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
[TBL] [Abstract][Full Text] [Related]
13. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
14. Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.
Riaz M; Ragsdale BD; Rahman ZU; Nigam G
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28830901
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of DRESS syndrome.
López-Rocha E; Blancas L; Rodríguez-Mireles K; Gaspar-López A; O'Farrill-Romanillos P; Amaya-Mejía A; Galindo-Pacheco L; Campos-Romero F; Aguilar-Hinojosa N; Suárez G
Rev Alerg Mex; 2014; 61(1):14-23. PubMed ID: 24912998
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
17. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients.
Sultan SJ; Sameem F; Ashraf M
Int J Dermatol; 2015; 54(5):537-42. PubMed ID: 24738653
[TBL] [Abstract][Full Text] [Related]
18. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
19. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
E L omairi N; Abourazzak S; Chaouki S; Atmani S; Hida M
Pan Afr Med J; 2014; 18():9. PubMed ID: 25360193
[TBL] [Abstract][Full Text] [Related]
20. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
